Sudarshan Chemical Industries Limited (BOM:506655)
India flag India · Delayed Price · Currency is INR
1,155.60
+2.20 (0.19%)
At close: Nov 17, 2026
← View all transcripts

Q2 26/27

Nov 6, 2026

Summary

Q2 global pigment revenue rose to INR 2,695 crore and business EBITDA to INR 242 crore. Priorities are customer recovery, cost reductions and integration, with FY27 acquired-operations guidance reaffirmed.

Operator

Hello. We'll begin the call. Thanks everyone for joining in. On this auspicious occasion of Dhanteras, we wish everyone a Shubh Dhanteras and Diwali. We thank Q2 FY 2027 Earnings Conference. Chairman and MD, Mr. Rajesh Rathi, Mr. Nilkanth Natu, CFO, and Mr. Amey Athalye, Vice President Finance from Sudarshan Chemical Industries. I would like to hand over the call to Rajesh sir for his opening remarks, post which we will have a Q&A session. Thanks, and over to you, sir.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Thank you. Thank you, 360 ONE, and 360 ONE Capital Market Research, and Rohit Nagrajji, especially for hosting our investor call. Happy Dhanteras, Rishi, to all of you all. We just declared the results today, and I'm very glad that we had a good quarter, and very glad to present the results to you all. As all of you all are aware, we've integrated two entities, Clariant, Heubach legacy, and Sudarshan legacy. Today, we are ONE Sudarshan, one of the most value-adding pigment player rooted in customer centricity, innovation, and agility. To give you an integration update, as we had mentioned last time that we've been focusing on innovation, and this is just the start, and we are doing several areas where we are working on heavy metal-free dyes, bringing in new innovation to high-end industries like cell phones, digital inks, right?

We are working on recycled plastics, colors for recycled plastics, agro, et cetera, and our innovation update has been very good. The second important aspect has been that there was a toll manufacturing agreement with Clariant for manufacturing aluminum dyes, and we've acquired this manufacturing. We've signed definitive agreements to get this manufacturing business, and we expect to close this early next year. On the VP4, we sold one of the raw materials which we were producing. A small amount of that raw material was used by us, but otherwise, that majorly the raw material was going to one of our customers, and we sold this business to the customer. We've closed this deal on November 2nd at a value of EUR 75.8 million, and we've received all the funds, and all the carve-out activities have been successfully completed.

From a value capture perspective, we continue to focus on deriving value capture, reducing costs. The fifth is, as ONE Sudarshan integration, one of the important aspects has been the culture and system integrations. System-wise, we were using four SAPs. We were using 130 different applications. We are integrating these into one, and we'll have one system going live. We've gone live on wave one, which includes Sudarshan legacy and Heubach India legacy. On the other aspects, we are making good progress, and I will talk a little more as we go ahead. As I spoke about innovation to all of you all, we've launched several products into the cosmetic, cell phone industries, and also recycled plastics, right? As I mentioned, this is just one sign to show you all that we've reopened the innovation pipeline. Sorry. Yeah.

In terms of aluminum dye business, as I mentioned, this business serves consumer goods and architectural coatings. The manufacturing, we had a toll manufacturing agreement, which we have signed definitive agreements to get this business, get this manufacturing site. VP4, as I mentioned, we have closed the deal, and we have received EUR 75.8 million, which these funds will be used to reduce the debt of the company. Talking about the performance of the company now. Generally, if you see, the overall U.S. housing and European construction are still weak. The masterbatch, because of the volatility in oil prices and hence the polymer prices, the masterbatch demand has been very volatile. This has been one of the areas to kind of and challenges, external challenges for us, external, I would call headwinds for us to kind of look at this. But some of the indicators have been positive.

European manufacturing PMI has moved positively, and certain raw material prices have stabilized. We expect signs of demand uptake towards Q4, maybe not right away. We are ensuring that we have to ensure that we are retaining some of the volumes. In terms of the pigment performance, as the table can be kind of, Natu will take us through the details, but how we have organized this is Legacy Sudarshan, Acquired Group, and the pigment total global business. Natu will highlight some of the areas and performances.

Nilkanth Natu
CFO, Sudarshan Chemical Industries

Thank you, sir. For the q uarter two Financial Year 2027, the quarter under review, the Legacy Sudarshan pigment business revenue from operation is at INR 821 crore compared to INR 730 crore Q1 of FY 2027 and INR 651 crore of the last year. The EBITDA is at INR 128 crore for the quarter under review, and the EBITDA percentage is at 15.6%. For the Acquired Group, the quarter under review shows the consistent performance in terms of the revenue. The revenue is at INR 1,962 crore and with INR 112 crore EBITDA for the quarter. Total pigment global business for the quarter shows the revenue of INR 2,695 crore and with the business EBITDA of INR 242 crore compared to last year, same quarter of INR 2,327 crore of revenue and with INR 90 crore of the EBITDA. It shows a good upswing compared to the last year Q2.

This is a bridge between the business EBITDA and the reported EBITDA for the Acquired Group. The business EBITDA is at INR 112 crore, and there has been the inventorized overhead from increase in the stock, which is of INR 22 crore. The reported EBITDA for the quarter for Acquired Group is at INR 134 crore. This is a pigment performance for the first half of the financial year. Just to take couple of key numbers, revenue from operation for Legacy Sudarshan business is at INR 1,551 crore, shows the growth of 26%. Business EBITDA is at INR 255 crore compared with INR 172 crore last year. The percentage is at 16.5% for the first half of the year.

Acquired Group revenue for the first half of the year is at INR 3,935 crore, with business EBITDA of INR 240 crore, and the EBITDA percentage is at 6.1% compared with the last year of INR 3,565 crore of the revenue and INR 70 crore of the EBITDA, which was at 2%. The RIECO performance for the quarter two FY 2027, the revenue from operation is at INR 47 crore. Company is facing execution challenge due to the supply chain bottleneck, which is internal. For the first two quarters, we had seen the performance subdue. The EBITDA for the quarter is INR -3 crore. For first half of the year, the revenue is at INR 85 crore with negative EBITDA of INR 13 crore, vis-a-vis the last year of INR 111 crore of the revenue and the INR 6 crore of EBITDA.

One of the reasons for this performance also is execution challenge, as I mentioned, which has reflected in the revenue. Two late-stage projects have seen the cost overrun, which has been fully accounted during the quarter. This is ONE Sudarshan performance, and ONE Sudarshan performance includes the RIECO performance as well. Legacy Sudarshan includes RIECO performance. The key number is revenue from operation is at INR 868 crore versus INR 712 crore of the last year. The business EBITDA is INR 126 crore compared with the INR 91 crore of Q2 last year and INR 118 crore of Q1 FY 2027. No change in the Acquired Group numbers. For the half yearly performance of ONE Sudarshan, including RIECO, the Legacy Sudarshan business revenue is at INR 1,636 crore versus INR 1,340 crore revenue last year, H1, growth of 22%.

The business EBITDA is at INR 243 crore versus INR 178 crore last year, shows the healthy improvement in the EBITDA. No change in the Acquired Group for H1. In terms of the financial ratios, the earnings per share for first half of the year is 26.2, which is before exceptional expenses. Return on Capital Employed is at 22.6%. Net debt to equity shows healthy ratio of 0.2. Net debt is at INR 580 crore. Net working capital is at 25.3%. The key balance sheet ratios show significant improvement. One of the areas where management will be further focusing on is on the net working capital efficiencies to drive in the coming quarters.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

I think, just to kind of caution that this is without in November, we've received the money from the VP4 sale.

Nilkanth Natu
CFO, Sudarshan Chemical Industries

Yeah.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

So that's not included in this, right? You want to-

Nilkanth Natu
CFO, Sudarshan Chemical Industries

Yes. So this INR 580 crore net debt number is the position as of September end. We have closed VP4 deal, and the funds has been received on 2nd November . This particular amount which we have received is not included in the net debt.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Thank you. In terms of the outlook, I think Sudarshan has completed a strong H1 with healthier profitable and momentum, as one of the largest global pigment platforms backed by a very broad technology depth and a global footprint that supports supply resilience, right? With this, given the external situation is very challenging, we are cautiously navigating a challenging market environment given the geopolitical uncertainties, the raw material costs, the logistic cost increases. But at the same time, we are winning back trust of our customers and some of the lost sales. So, once the external environment improves, I think we should have a better revenue growth too, right? The third focus remains the SAP integration, a major challenge before us, and we expect to complete this by mid-next year, right?

We want to reaffirm strongly our guidance for the Acquired Group, EUR 700 million and EUR 35 million of EBITDA. Thank you.

Nilkanth Natu
CFO, Sudarshan Chemical Industries

Thank you, Rajesh.

Operator

Request participants to. Thanks. Request participants to ask only two questions per participant, and raise your hand, and we will let you speak. Nitesh, you can go ahead.

Nitesh Dhoot
Analyst, Anand Rathi

I hope I am audible.

Nilkanth Natu
CFO, Sudarshan Chemical Industries

Yes.

Nitesh Dhoot
Analyst, Anand Rathi

Hi, team. Good evening, and congratulations on a good set of numbers. My first question is, sir, how much of this improvement coming through on the revenue side is from volumes, and how much is because of the price pass-throughs? And related one is, have we been able to gain back some of our lost market share during the previous Heubach insolvency period, or it is still underway?

Nilkanth Natu
CFO, Sudarshan Chemical Industries

I would like to divide your question. When you look at Legacy Sudarshan sales, there were three aspects, right, from it. As we were going live on SAP, from a Sudarshan perspective, we had requested customers to buy material and keep, as during the 1st October week, we were going live. So certain sales got booked in September, right, of which in a normal course of business could have been October. The second business, of course, there is a volume growth, and I would divide it into half and half, right, from that perspective, given this other factor not being there, and the rest is all good. On the Acquired Group, we have some volume growth, muted volume growth, but rest is all price increase.

And we have been able to gain business and trust of all our global key accounts, and several of the businesses are coming back to us. But of course, this is an ongoing process, but we are well on that track.

Nitesh Dhoot
Analyst, Anand Rathi

Sure, sir. My next question is on the EBITDA guidance for the Acquired Group. So, EUR 35 million is what you had guided for full year. I think we are already 2/3 done, but we still haven't upgraded our FY 2027 guidance. So, any particular reason for being conservative here? Are we looking at a probably weak quarter ahead, repeat of Q3 last year, or what really is the reason? I mean, a light question to this would be that the VP4 sale, where we are having to give up EBITDA, is that also getting accounted for in this retained guidance?

Nilkanth Natu
CFO, Sudarshan Chemical Industries

In the retained guidance, we've taken that into account, that the VP4 sale is gone. I think Q3 last year was quite a subdued quarter. We don't expect such a subdued quarter this quarter, but we are tending cautiously because this is the first normal-

Two, three quarter, right, which we are going to experience as we have acquired this business. Hence, we are keeping the guidance as today.

Nitesh Dhoot
Analyst, Anand Rathi

All right. Just a connected question to this, just a clarification, not a question exactly, but your captive use for this VP4, I mean, it was mentioned as 5% earlier, but your November deck, I mean, your current presentation says it is about 10%. What is the correct number there? If you could just clarify.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Just one sec. Nitesh, it is between 5% -1 0%, I think a very low amount depending on the demand situation, right? I mean, the matter of fact is it is quite low, right? In the single digit.

Nitesh Dhoot
Analyst, Anand Rathi

Got it. Sure. Sure, sir.

Operator

Hello. Next question, Sanjesh, you can go ahead.

Sanjesh Jain
Assistant VP of Equity Research, ICICI Securities

Okay. Thank you. Thanks for unmuting. Good afternoon, sir. Thanks for taking my question. First question again on the revenue growth. How are we looking in terms of product portfolio on the R&D side, the pipeline of product, and what gives us the confidence that we will be able to accelerate growth, say, in CY 2027?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Sanjesh Jain, I think as we've explained, we have a very broad portfolio of products. What we are doing is we are leveraging our technical marketing and innovation teams to work very closely with customers to come up, and I just gave you a glimpse of some of our new launches which we've just done, right? Which gives a flavor of how the engine has started moving forward, right? What gives us the confidence is, I think, given the external situation normalizes and the demand returns, I think we've been able to win back a lot of trust with the customers. This will give us some room of growth coming forward.

Sanjesh Jain
Assistant VP of Equity Research, ICICI Securities

But can you help us understand geographically, because now we are a global player.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Yes.

Sanjesh Jain
Assistant VP of Equity Research, ICICI Securities

Which are the geographies where we are seeing attraction, where we are working very closely with the technical team? What kind of the application are we looking at, where we are seeing early sign of deal wins and new contracts or any inquiries coming in?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Sanjesh Jain, one area we were working on is lot of lost business, right? Lot of lost sales. These were global key accounts who are mainly based in Europe and U.S., right? They have a global presence, but I think the majority of and they have a global demand, but I think their key contacts are based there, right? This is one area where we have worked very closely together. This is across industries, but I would say the main industries which is giving us this demand is coatings and digital inks, right?

Sanjesh Jain
Assistant VP of Equity Research, ICICI Securities

Coatings and?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Digital inks.

Sanjesh Jain
Assistant VP of Equity Research, ICICI Securities

Digital inks. Okay. What are the areas where we have lost the sales during this transition, and which are the players who have gained, and what gives us confidence that the customers will come back?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

We lost business across industries. Again, this is lost to. It is not a concentrated portfolio where one or two suppliers have gained in. It has been a loss across. What gives us the confidence is we have already seen some of this business come back. It is not just talk now. We are seeing some of the business come back. I think to the fullest extent would take some time to build that up.

Sanjesh Jain
Assistant VP of Equity Research, ICICI Securities

One last question from my side before I come back on the queue. We are trying to be a more cost-competitive player, working on the innovation of the European player and having the learnings of India cost structure. Are we trying to place ourself as a value play or an innovation play when we go to the customer?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

I think there are two parts. I think one is bringing innovation to the customer is the important part of bringing back the energy back in the relationship. The matter of fact was that we had a very high fixed cost which we needed to shed and which would improve our performance. These are the two aspects.

Sanjesh Jain
Assistant VP of Equity Research, ICICI Securities

Are we taking cost as a play?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Sorry?

Sanjesh Jain
Assistant VP of Equity Research, ICICI Securities

Are we taking cost as a play to win back the customers now that-

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

No, I can't.

Sanjesh Jain
Assistant VP of Equity Research, ICICI Securities

We can play around with it?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

I don't think that's our saying that our drive towards the customer saying that we are cheap and buy from us, right? I think some areas where we are not cost-competitive at all, we're trying to reduce our costs. I think the cost plays more to improve our own performance, right?

Sanjesh Jain
Assistant VP of Equity Research, ICICI Securities

Okay.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Then gain market share.

Sanjesh Jain
Assistant VP of Equity Research, ICICI Securities

Got it, sir. Got it. Very helpful. Thanks for answering all those questions, and best of luck for the coming quarters, and Happy Diwali, sir.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Thank you, sir. Same to you.

Sanjesh Jain
Assistant VP of Equity Research, ICICI Securities

Thank you, sir.

Operator

Next question is from Viraj Mahadevia. Hi, Viraj, you can go ahead.

Viraj Mahadevia
Portfolio Manager and Partner, MoneyGrow

Hi, Mr. Rathi. Congratulations on the transformation journey of the group. A couple of questions from my side. One is, in your current results, you announced a INR 74 crore employee restructuring in Germany. Can you give us a little bit of more detail around that? What does that entail? Is it largely plant labor headcount? What are the other kind of costs? And how much will be the annual savings coming out of this restructuring exercise?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Thank you, Viraj , and I think this is related to the earlier announcement which we had made regarding reducing the headcount in Europe.

Viraj Mahadevia
Portfolio Manager and Partner, MoneyGrow

Right.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

These are mainly related to all the support functions, right? Not the direct manufacturing functions.

Viraj Mahadevia
Portfolio Manager and Partner, MoneyGrow

Okay.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

The savings should be similar or slightly a higher amount than this per annum.

Viraj Mahadevia
Portfolio Manager and Partner, MoneyGrow

Fantastic. That will start reflecting in Q3 itself?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

No, no. It will take one year because the agreement is by this financial year-end, by then people will go away.

Viraj Mahadevia
Portfolio Manager and Partner, MoneyGrow

Understood.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Start going away.

Viraj Mahadevia
Portfolio Manager and Partner, MoneyGrow

Understood, sir.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Gradually come in over the next 1.5 y ear, sir.

Viraj Mahadevia
Portfolio Manager and Partner, MoneyGrow

Excellent. My next question is, if I look at the group now after the VP4 divestment, your net debt as of last quarter was 100-odd crores. You sold this business for INR 800 crore-INR 850 crore. You are acquiring a small business potentially for CHF 7 million. So you should be meaningfully net cash by the year-end. Given that the steady build in the business and the operation synergies, the business should be generating cash flows, meaningful cash flows in 2027 and especially in 2028. Given the lack of future CapEx investments, given that now you have a global footprint in all these plants, has the promoter group considered doing company buybacks given the low promoter shareholding and the attractive share performance in terms of value?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Viraj , I think not the promoter group, but I think as a board, we are looking at-

Viraj Mahadevia
Portfolio Manager and Partner, MoneyGrow

As a board, yes.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

As a board, we are looking at all options and what makes sense. But more importantly, I think the board is also trying to look at saying that, how are we going to use this cash so that we are able to give a better return to our shareholders, right, for the future? And so that thinking, apparently, we were first waiting that the full transformation is completed and then we start thinking about it. But the board has been pushing us to actively look at the right usage for the cash for the future. We will, probably in a year's time, we will have a full-fledged plan on how we will actively look at this too.

Viraj Mahadevia
Portfolio Manager and Partner, MoneyGrow

Understood. Thank you very much. I will get back in the queue.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Thank you, Viraj.

Operator

Next question is from Love Gupta. Love, you can go ahead.

Speaker 7

Thank you for the opportunity. I just wanted to ask, have we considered a merger with Sudarshan Colorants so we can simplify our corporate structure instead of having two listed entities operate as one and do away with the minority interest as well?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Gupta , I think there are several aspects which the board is looking at. But given that there are too many moving parts, I think we will come back to this in some time. Currently, I think we are looking at how to improve our operations, how to integrate our systems, et cetera, and then look at some of the structural changes.

Speaker 7

Got it.

Operator

Next question is from Manjit Bawria. Hi, Manjit, you can go ahead.

Speaker 8

Hi. Thank you for taking my questions. Sir, the first question was, under the previous private equity ownership, were there any key business areas was there really under-invested in the business over a span of three, four years in which we need to now correct? If you could give some color on what they were?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Can you repeat your question, sir? I didn't follow you.

Speaker 8

No, I was checking, before we acquired the business, global business, it was private equity owned, right? So I wanted to understand, were there any business areas where they were under-invested?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

I think Heubach was, yes, by private equity. I think there were several concern issues and learnings for us that I think the integration between the two entities had not happened. There were several, not that, but before that also, I think the investment in innovation, et cetera, had stopped, and technical investments in the business had stopped, which we have rewired. There was also a lot of overhead, which we've tried to reduce and streamline the org structure.

Speaker 8

Okay. In the current org structure, sir, in the key leadership roles for the Acquired Group, do we have to refill many of these roles? Have those people left, or you have seen reasonable continuity in the positions where you wanted it to be that group?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

What we've done is, sir, we've integrated the organization into a functional organization across legacies, right? We've ensured that we have a lean structure, but the competency is not lost. Exactly as per our design, we've been able to reduce a lot of overhead and fat from that perspective.

Speaker 8

No, sure, sir. I understand the excess sort of people not being there. I was asking more in terms of the people you wanted to retain in leadership roles. Do you have to take them from India, or do you have to hire for those roles, or the people who are there or erstwhile organization, they've continued with us?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

We worked on a meritocracy basis. We have a functional organization, and whether the functional head sits in India, Europe, U.S., is irrelevant, but I think we've chosen the best. From that perspective, and we've been able to retain most of the critical talent. We've also done some rehiring in some areas. But I think all in all, the org structure is quite well set, sir.

Speaker 8

Got it. Sir, and one last question. In the Q1 presentation, you had given a FY 2029 aspiration on revenues and EBITDA. The EBITDA there implied about close to 12% EBITDA margin. I just wanted to understand the bridge between the current 9% levels to that 12%. Will that heavy lifting be done by the Acquired Group EBITDA, or is there scope within India as well to improve the EBITDA from where they already are in our Legacy Sudarshan business? Thank you.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

I think most of the improvement, Manjit , came from the Acquired Group. Of course, there is some scope within the Legacy Sudarshan business also to improve, but most of the improvement came from the legacy. Came from the-

Speaker 8

Sir, I talked about the forward-going, where you had given FY 2029 vision you had.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Yes. I am talking about that only, sir.

Speaker 8

Oh, okay. Got it. Thank you, sir. Thank you so much.

Operator

Hello, Archit. You can go ahead.

Archit Joshi
Director, Nuvama Wealth Management

Yeah, thanks. Good evening, everybody, and first of all, wishing you all a very happy Diwali and Dhanteras. Sir, I just have one question. When we had made the acquisition at Heubach, and we were speaking quite a lot about value capture initiatives, and you have elaborated that in the presentation also. But I think some of the areas that we were discussing last time around was shifting commodities to low-cost regions, sourcing optimization, backward integration, SAP integration. I think these were some of the key areas that we spoke of. And I guess at a business EBITDA level, we have done quite well. On margins, I think we are at about 6%-6.5%.

From the time of acquisition till now, if you could help us, what are the things that we have been able to achieve on capturing the value, and what would be the things that are still pending for us to reach that EUR 90 million-EUR 100 million mark that we are planning over the next three to four years? That would be helpful, sir. Thank you.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Thank you. Great question, Archit . Firstly, I think what we've worked on is, as you mentioned, this has been our number one set of our priorities was to win back trust with our customers, right? The second part was to get value capture and reduce costs, right? I think some of the areas which we've been able to reduce costs are first on the org structure build, right? We've done a lot of work and reduced costs there. Second is manufacturing cost reduction, right? So we've really worked across, whether it's yield improvements, throughput improvements, utility cost reductions across our sites. The third has been purchase cost reduction, looking at more global buying, looking at Asia-based buying globally. These are some of the areas we've been able to achieve. The third is IT integration. IT integration had two phases.

One is, of course, cost reduction, but also looking at how we are able to reduce our costs, right? As I mentioned, the transactions which we are doing today are four transactions. We have four SAPs. Consolidating them into one, right? These are some of the aspects which we've been able to do well. The IT integration is still in progress, but we've made considerable progress in these areas, right? What we've not done so far is any backward integration, right? We want to kickstart some of the backward integration projects. The second is use of artificial intelligence or AI in the business. This is the second leg which we've not still kind of leveraged. So, we still have a lot of scope still in purchase manufacturing, but these are some of the additional levers to kind of reach the target margins.

Archit Joshi
Director, Nuvama Wealth Management

Right, sir. Sir, these are the initiatives. Would that help in like a 300-400 basis points swing on margins? Since we are at, let's say, 6%-6.5%, and I think at EUR 90 million-EUR 100 million, we would reach near about 9%-10%. Would backward integration and implementation of AI, if these are the two larger areas we are targeting, would that facilitate that 300 basis points swing? Or would there be anything else with regards to some more optimization on sourcing or-

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Yes.

Archit Joshi
Director, Nuvama Wealth Management

Or product mix or something like that, sir?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Absolutely, sir. I think these things would, as I mentioned, there is still manufacturing and procurement more work to be done. In addition to that, the backward and this integration. But we are also hoping that we are able to bring back some business and get operational leverage, right? We should be able to get one or two percentage of EBITDA from there, right? I think all these we should be able to kind of bridge this margin.

Archit Joshi
Director, Nuvama Wealth Management

Sure, sir. Just one last bit if I can squeeze in. The production mix that we are planning, the commoditized ones into places like India, has that completely been done or that is also left to a certain bit?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

The production has been moved, sir, but I don't think we've got the full mileage. We've not been able to still fully commercialize those businesses. That's a scope where we can win some.

Archit Joshi
Director, Nuvama Wealth Management

Right, sir. Great. Thanks a lot for answering all the questions, sir. Again, wishing you a very happy Diwali. Thank you.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Same to you, sir. Same to you.

Operator

Hi, Niharika, you can go ahead.

Speaker 10

Hello?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Yes, ma'am.

Operator

Yes, you can go ahead.

Speaker 10

Yeah. I understand that much of the EBITDA margin improvement will come from the Heubach business. We have seen improvement already in last couple of quarters. Just want to understand what is the kind of levers which would drive further improvement in margins. That is first. Is there any operational or structural issue which the Heubach business is still facing? My second question is on the inventory destocking. Has the overhang reduced or is still residual destocking pending? Is there any other further negative surprises on this front?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Ma'am, the first question, I had two parts. I did not understand the second part of the question.

Speaker 10

It was related to what would be the levers that would drive Heubach business EBITDA margin improvement?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Yeah. I think as I mentioned, ma'am, I think there are two aspects. One is a strong value capture in operations, purchase, organization structure, kind of streamlining that, right? And further leveraging some of the backward integration. There is a lot of IP on backward integration and use of AI, right? These are the levers which would give us a lot of value capture initiatives. Plus, we are hoping that we are able to drive some EBITDA growth from growth too. So, a small amount from there, right? These are the levers which will help us improve our performance.

Speaker 10

Okay. Understood. My second question was on inventory destocking. So, what is the current status right now and-

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

From the customers-

Speaker 10

Yeah.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

From the customers' bit, I think the destocking is over, and I am hoping that it is over because it cannot be forever and ever, right? But we do not see a destocking impact now coming in, right? But in fact, it is the high inventory scenario, so customers are buying only when there is a requirement, right? They are not stocking up enough, right? But of course, there is a general external geopolitical uncertainty which keeps the demand, and hence the demand is mute.

Speaker 10

Okay. If I could just squeeze in one more. The global pigments industry is growing at roughly 3%-4% annually. In the last time, the guidance for Sudarshan was given for 9% till FY 2029. We know this kind of slowdown that you just spoke about in Europe and U.S. in the automotive and decorative paints industry. What gives us confidence that Sudarshan would be able to beat the global pigment industry growth rate?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

I think the first is, our thesis was that we will be able to win back some of the businesses which we've lost. That will give us some growth. That is first aspect. But given that, I mean, our aspiration to grow EBITDA, like I said, 2/3 of the aspiration, 2/3 of it comes more from internal cost reduction. Maybe 1/3 of the EBITDA growth comes from driving sales up, right, from that perspective.

Speaker 10

Yeah. Just one thing. I understand the drivers that you spoke about, but 3%-4% and us growing by 9%, do you think there is a lot of divergence there?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

No, I think I just mentioned that we've lost a lot of sales, and we want to regain the sales, and that's where the growth would come in.

Speaker 10

Understood. Okay. Thank you.

Operator

Hello, Rohit sir, you may go ahead.

Rohit Nagraj
Head of Sector of Chemicals, 360 ONE Capital

Thanks for the opportunity. Congrats on a strong Q2 FY 2027 and becoming debt-free within two years of acquisition. My first question is, we have monetized VP4. Are there any such more pieces which could be monetized at some point in time, and will that add to, again, getting more into core and offsetting the non-core businesses? Thank you.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Hi, Rohit . I would say, I wish that there were more, but I do not think there are any such low-hanging fruits anymore, right, from that perspective. So, I think this was our original thesis when we did the acquisition, right, of getting this. But we had never anticipated that we would. Our anticipation on value was lower that time. But I think, given when we looked at in-depth numbers, et cetera, that is where I think we looked at VP4 from that perspective.

Rohit Nagraj
Head of Sector of Chemicals, 360 ONE Capital

Got it. Thank you. Second question, on slide 10, we have provided the innovation and a new pipeline. In terms of, generally, on a yearly basis, how many of such new products are we working on? And in terms of monetization of those products, what is usually the sales run rate that we look at when we are looking at these niche spaces? Thank you.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Rohit sir, I think, as I mentioned in my talk, I think this is re-energizing the organization and reaching the organization that we learn to listen to customers, anticipate what are their unmet needs, and go back to the market with innovations where customers feel excited to work with us, right? This is an overall customer relationship management, which gives help to our existing business also, right? So, I think some of these new spaces take some time to click, but I think gives a good base for strengthening the relationship. And of course, these also help in improving the EBITDA, right? Because they are better margin products. Yeah.

Rohit Nagraj
Head of Sector of Chemicals, 360 ONE Capital

Right. Got that, sir. Thanks a lot for answering all the questions, and Diwali wishes to the entire team. Thank you.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Thank you, Rohit sir. Thank you so much.

Operator

Hello, Pawan, you can go ahead.

Speaker 12

Thank you, sir. Thank you for the opportunity. My first question is, you have mentioned that now you are restarting your innovation pipeline. Would that have a material impact on expenses? Would there be a cost coming out of this?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

The cost is already. The team is already part of it, so there is no additional cost.

Speaker 12

Okay. My second question, like you are mentioning, for Heubach, you are looking to recapture the lost business. Would you be gaining market share, or is your gaining market share from competitor, or what is the scenario there?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Yeah, we had lost market share, so we are going to regain that market share.

Speaker 12

Sir, what competitive edge we have vis-a-vis with our competitors there?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

I think that was the very basis that customers had lost trust in us, and we have regained that trust and regained that trust, the relationship, ensuring that we serve them well, rebuild relationships, and the reliability with them.

Speaker 12

Okay. Sir, any other acquisition in mind, like, or maybe strengthening your backward integration, or maybe some pieces where still you need maybe some more acquisitions?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

I think not for backward integration, but I think the management and the board kind of always keeps looking for opportunities, but nothing where it can expand our footprint, et cetera. But I think nothing. At the right time, of course, if we do find, we will come and talk about it.

Speaker 12

Okay. Thank you, sir. Thank you for answering all the questions. Happy Diwali to everyone, sir. Thank you.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Thank you.

Operator

Hello, Dhawan, you can go ahead with your question. Hello, Dhawan?

Speaker 13

Hello, can you hear me?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Yes, we can hear you.

Operator

Yes.

Speaker 13

My question is, for the Heubach, I think earlier you mentioned that 2/3 of our operating margins improvement would be largely coming from the cost synergy, wherein you are planning to do some cost rationalization. By when can we see the improvement? Based on your assessment, how much we have already done the cost saving till now from the acquisition date?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Now, some of the improvements which you have seen in EBITDA is part of that value capture and/or cost reduction, right, already. As I mentioned, we will continue this journey from that aspect to kind of keep improving our performance, right?

Speaker 13

From employee cost and the other operational cost perspective, let's say, the employee is roughly INR 1,500 crore, the annual run rate over there, and then the other cost is roughly INR 2,000 crore. Both together is roughly INR 3,500 crore kind of the cost. How much saving can we expect from these two things? By when can we expect this would be materialized in terms of the numbers?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

As you can see our performance, we are already this year clocking towards EUR 35 million of EBITDA. Going forward also, we have given the guidance. Most of this will come through the cost reduction on these areas which you have seen.

Speaker 13

Okay. In terms of the sales that customers which the earlier company lost because of some reason. I think we are planning to acquire those customers. At what stage are we right now, and by when can we expect that sales to flow in the Heubach?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Building the trust with the customers has given us rich dividends. We have already won back some of the businesses. As you may have seen our last year's performance in Q3, et cetera, Q2 was quite muted, and we have already seen a positive trajectory from that perspective. This process will continue the building. Having that the geopolitical uncertainty as it improves and the external situation improve, I am sure this will give us also rich dividends, and we will be able to see the full benefits.

Speaker 13

Sure, sir. Thank you. That is all from my side.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Thank you, sir.

Operator

Hello, Nitesh, you can go ahead.

Nitesh Dhoot
Analyst, Anand Rathi

Yeah, thank you. Thanks a lot for the follow-up. On the strategy side, sir, if you look at the aluminum dyes acquisition, so adding a Swiss site wherein while the value capture relies on footprint optimization. That is like acquiring something in Europe was not really on the cards, if I am correct. Is this Swiss site a long-term plant there, or will the technology move to India? How will it play? Are any more acquisitions in Europe that we might be evaluating?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Nitesh , sorry, there was some technical challenge. You were not able to unmute. Can you hear me, Nitesh ?

Nitesh Dhoot
Analyst, Anand Rathi

Yes, I can.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Yeah, Nitesh , absolutely. I think this is a very niche business, Nitesh , where the product approvals are very prudent to the site, right? So very sensitive to where it is produced, et cetera. And for the business continuity, this was very important, right, to have these assets. This business was being toll manufactured. The business belonged to us, but this was toll manufactured, these products, by Clariant for us. And Clariant, in the long term, didn't want to do this. And in order for us to continue the business, this was very important to maintain, get that site. Having said this, we do see a lot of opportunities in improving the cost base in that plant too, and we will definitely work on that.

Nitesh Dhoot
Analyst, Anand Rathi

Sure. That helps. Sir, just one last there. Management expected a further EUR 15 million-EUR 20 million inventory reduction coming through in FY 2027. However, if we look at the inventory days, I mean, that has actually gone up in the first half, if we have to look at. And even on the absolute number, I think it's up by 25% over the 31st March. Any color on the inventory side here?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Nitesh , spot on. I think if you see our performance to H1 of 2026, we have improved our performance, right? Compared to H1. There are some seasonalities, et cetera, but given the current geopolitical situation, right, the lead times for raw materials have increased a lot. The lead times for finished good deliveries have increased a lot, right? More variation in demand, right? All this has caused us to increase some of our inventories. Not exactly, not where we want to be, but given the situation, to manage this has been quite challenging, and that's where I think you've seen these increases. Having said that, compared to H1 last year, there is still an improvement, right? In number of days, in definitely number of days. And that's it.

Nitesh Dhoot
Analyst, Anand Rathi

Sure. Thanks a lot. Thanks a lot, sir. I think I wish entire team a very Shubh Dhanteras and a happy Diwali. Thank you so much.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

To you, sir. Thank you so much, man. Same to you.

Operator

We'll take the last question from Viraj Mahadevia.

Viraj Mahadevia
Portfolio Manager and Partner, MoneyGrow

Hi, Mr. Rathi. Thank you for taking my question again. Are there any unfunded pension liabilities from the Acquired Group of Heubach, or that is all been factored in into the deal consideration?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

No. Yes, sir, everything. There is no unfunded. There are none.

Viraj Mahadevia
Portfolio Manager and Partner, MoneyGrow

Excellent. The second one is, you talked about backward integration into India not having really kicked in, but are there spare capacities and technical capability to make a lot of these European products in India?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

The products, some of these products are not still made by us, right? But the IP exists between the two legacies, and that is what we want to get the potential out, right? So, exploit that and get that. So, that is where it is. So, it is not like a transfer of a manufacturing asset, but it is, I think, creating new capacity, starting to produce some of these molecules.

Viraj Mahadevia
Portfolio Manager and Partner, MoneyGrow

But the capacities are there. It is just transferring the skill set, is it? Or the setup?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

No, we do not make these products there, sir, but we have the IP, so we can make them in the lab. We do not have physical assets on this.

Viraj Mahadevia
Portfolio Manager and Partner, MoneyGrow

Okay.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

We can make it in the lab. We have people who know the know-how, et cetera. It is about putting actually metal on the ground in India for this.

Viraj Mahadevia
Portfolio Manager and Partner, MoneyGrow

Oh, so you would have to increase capacities to make them in India?

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Yes. Make an investment for that.

Viraj Mahadevia
Portfolio Manager and Partner, MoneyGrow

Excellent. Thank you. All the very best, and happy Diwali, and lots of Dhan.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Thank you, Viraj . Thank you so much.

Operator

Thanks, everyone. We hand over to the management for closing comments.

Nilkanth Natu
CFO, Sudarshan Chemical Industries

Thank you, Bhavin, for anchoring our call. Thank you, Rohit , for hosting our quarterly earning call. Thank you, participants, for your time and interest in Sudarshan Chemical. We remain confident in the long-term prospect of our combined business, and we look forward engaging with you again in future. Wishing you all a very happy Diwali. Thank you.

Rajesh Rathi
Chairman and Managing Director, Sudarshan Chemical Industries

Thank you.